Symbol="AVTE"
AssetType="Common Stock"
Name="Aerovate Therapeutics Inc"
Description="Aerovate Therapeutics, Inc., a clinical-phase biopharmaceutical company, is focused on developing drugs that improve the lives of patients with rare cardiopulmonary diseases. The company is headquartered in Boston, Massachusetts."
CIK="1798749"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 BERKELEY STREET, FLOOR 18, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="468943000"
EBITDA="-59779000"
PERatio="None"
PEGRatio="None"
BookValue="4.557"
DividendPerShare="0"
DividendYield="0"
EPS="-2.07"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.257"
ReturnOnEquityTTM="-0.415"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.07"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="4.548"
EVToRevenue="-"
EVToEBITDA="-10.78"
Beta="0.341"
num_52WeekHigh="30.79"
num_52WeekLow="13.81"
num_50DayMovingAverage="17.46"
num_200DayMovingAverage="20.67"
SharesOutstanding="27601100"
DividendDate="None"
ExDividendDate="None"
symbol="AVTE"
open="16.40"
high="17.16"
low="16.05"
price="16.99"
volume="51011.00"
latest_trading_day="2023-07-21"
previous_close="16.28"
change="0.71"
change_percent="4.3612%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="93"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="7"
Volume_recent_avg="83038"
Change_recent_avg="-0.05"
Delta_recent_avg="1.54"
Variance_recent_avg="0.77"
Change_ratio_recent_avg="-0.32"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="7"
Aroon_momentum_negative="93"
image_negative_thumbnail_id_1="1157"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0191.jpeg"
image_negative_thumbnail_id_2="129"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0047.jpeg"
image_neutral_thumbnail_id_1="529"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_neutral_thumbnail_id_2="572"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0027.jpeg"
image_positive_thumbnail_id_1="703"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0005.jpeg"
image_positive_thumbnail_id_2="651"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0057.jpeg"
image_professor_thumbnail_id_1="1193"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
